A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Clinical trial NCT05202353 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05202353
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2026-12-18
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.